B04.014.004 | Vaccination with imported 13-valent pneumococcal conjugate vaccine, Prevenar | 3000.0 |
B04.014.004 | Vaccination with domestic liquid Tetanus and Diphtheria Toxoids Adsorbed with reduced antigen content, ADS-m-anatoxin | 800.0 |
B04.014.004 | Vaccination with domestic liquid Tetanus Toxoid Purified Adsorbed with reduced antigen content
AS anatoxin | 800.0 |
B04.014.004 | Vaccination with imported influenza subunit inactivated vaccine
Influvac | 1000.0 |
B04.014.004 | Vaccination with imported diphtheria-tetanus acellular pertussis vaccine
Infanrix | 2400.0 |
B04.014.004 | Vaccination against diphtheria, tetanus, pertussis (acellular), polio (inactivated), Hib infection and hepatitis B, with imported hexavalent vaccine
Infanrix Hexa | 3500.0 |
B04.014.004 | Vaccination against rubella with domestic cultured live attenuated vaccine | 800.0 |
B04.014.004 | Vaccination against meningococcal infection with Menactra-meningococcal polysaccharide vaccine (serogroups A,C,Y and W-135) conjugated with diphtheria toxoid | 7000.0 |
B04.014.004 | Injection and evaluation of Mantoux test with domestic purified tuberculous allergen in standard dilution | 1100.0 |
B04.014.004 | Vaccination for prevention of rotavirus infection with imported live pentavalent vaccine
RotaTec | 2900.0 |
B04.014.004 | Vaccination with imported inactivated hepatitis A vaccine
Havrix 720 | 1800.0 |
B04.014.004 | Vaccination with imported inactivated hepatitis A vaccine
Havrix 1440 | 2300.0 |
B04.014.004 | Vaccination with domestic inactivated hepatitis A vaccine
Algavac M (1.0 ml) | 1500.0 |
B04.014.004 | Vaccination with imported inactivated polio vaccine
Poliorix | 1300.0 |
B04.014.004 | Vaccination with imported inactivated split vaccine for influenza prevention
Vaxigrip - 0.5 ml. | 1000.0 |
B04.014.004 | Vaccination with domestic Pertussis-Diphtheria-Tetanus Adsorbed Vaccine (DTP) | 800.0 |
B04.014.004 | Vaccination with imported combined live vaccine against measles, rubella, and mumps
Priorix | 1500.0 |
B04.014.004 | Vaccination against measles, rubella, and mumps, imported, MMR II | 1500.0 |
B04.014.004 | Vaccination with domestic measles cultured live vaccine | 500.0 |
B04.014.004 | Vaccination with domestic mumps cultured live vaccine | 700.0 |
B04.014.004 | Vaccination with domestic mumps/measles cultured live vaccine | 800.0 |
B04.014.004 | Vaccination with imported polysaccharide polyvalent pneumococcal vaccine
Pneumo 23 | 2500.0 |
B04.014.004 | Vaccination against human papillomavirus (types 16,18) with bivalent recombinant imported vaccine Cervarix | 5500.0 |
B04.014.004 | Vaccination against human papilloma virus (types 6, 11, 16, 18) with recombinant imported quadrivalent vaccine
Gardasil | 8500.0 |
B04.014.004 | Vaccination against hepatitis B virus with domestic vaccine
Regevac 0.5 ml. | 900.0 |
B04.014.004 | Vaccination against hepatitis B virus with domestic vaccine
Regevac 1.0 ml. | 1000.0 |
B04.014.004 | Vaccination against viral hepatitis B with
Combiotex for children | 900.0 |
B04.014.004 | Vaccination for the prevention of diphtheria, tetanus, pertussis (acellular), polio (inactivated), Hib infection with imported vaccine
Pentaxim | 2950.0 |
B04.014.004 | Vaccination against yellow fever | 1500.0 |
B04.014.004 | Vaccination against typhoid fever | 1200.0 |
B04.014.004 | Vaccination against varicella, Varilrix | 3200.0 |
B04.014.004 | Vaccination against tick-borne encephalitis, liquid,
Tick-E-Vac | 1100.0 |
B04.014.004 | Immunoglobulin for vaccination against tick-borne encephalitis 1 ml per 10 kg of body weight.
(the cost of each subsequent ml of immunoglobulin - 700,0 rubles.) | 950.0 |
B04.014.004 | Vaccination against polio with Imovax polio | 1500.0 |
B04.014.004 | Vaccination for the prevention of menigococcal infection with Mencevax | 2500.0 |
B04.014.004 | Vaccination with live polio vaccine
Bivac polio | 450.0 |